drugset / Trial / NCT07295054
3 mL Inhaled Methoxyflurane for Intrauterine Device (IUD) Insertion
RandomizedParallel-groupTriple-blindTreatment
Summary
Intrauterine device (IUD) insertion is a common contraceptive procedure often associated with moderate to severe pain, particularly among nulliparous individuals. Current pain management strategies, such as over-the-counter analgesics, are frequently inadequate. Methoxyflurane, a short-acting, self-administered inhaled analgesic, has been shown to provide rapid and effective pain relief in acute and procedural settings. This study aims to evaluate whether 3 mL of inhaled Methoxyflurane (via Penthrox inhaler) improves patient satisfaction by reducing pain and anxiety during IUD insertion.
Timeline
- Start
- 2026-04-27
- Primary completion
- 2026-12
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methoxyflurane | Small molecule | 3 ml | Inhaled |
Indications
No indication recorded.